Agilon Health Return on Equity

Agilon Health (AGL) currently reports a ROE of -110.39%. That is below the Healthcare sector average of 20.77%. Use the charts on this page to explore Agilon Health's ROE history and peer comparisons.

Agilon Health's ROE of -110.39% is lower than the Healthcare sector average of 20.77%. That is roughly 631.6% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Agilon Health's current -110.39% should be judged against Healthcare norms (sector average: 20.77%) and against AGL's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -110.39%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 20.77%. From there, open related valuation or income-statement pages for Agilon Health, and consider following AGL for alerts when major investors trade the stock.

Agilon Health is classified in the Healthcare sector. On ROE, it currently shows -110.39% versus a sector average near 20.77%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AGL with unrelated industries.